We are live on ! Find out more
HM

Harvest Management Portfolio holdings

AUM $206M
1-Year Est. Return 95.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+95.44%
3 Year Est. Return
+609.22%
5 Year Est. Return
+2,730.08%
10 Year Est. Return
+91,890.88%
AUM
$71.8M
AUM Growth
-$1.04M
Cap. Flow
-$4.16M
Cap. Flow %
-5.79%
Top 10 Hldgs %
65.98%
Holding
77
New
23
Increased
11
Reduced
7
Closed
29

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.32M
2
CELG
Celgene Corp
CELG
+$2M
3
WBC
WABCO HOLDINGS INC.
WBC
+$1.99M
4
ALDR
Alder Biopharmaceuticals
ALDR
+$1.83M
5
CBM
Cambrex Corporation
CBM
+$1.8M

Top Sells

Rank Stock Value
1
RHT
Red Hat Inc
RHT
+$13M
2
APC
Anadarko Petroleum
APC
+$7.76M
3
WP
Worldpay, Inc.
WP
+$4.29M
4
CTRL
Control4 Corporation
CTRL
+$2.38M
5
ARRY
Array Biopharma Inc
ARRY
+$1.97M

Sector Composition

Rank Sector Weight
1 Healthcare 39.49%
2 Technology 9.73%
3 Materials 6.34%
4 Consumer Discretionary 4.47%
5 Energy 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLK
26
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$683K 0.95%
+26,282
New +$580K
AAPL icon
27
Apple
AAPL
$4.95T
$672K 0.94%
12,000
– –
AAPL icon
28
PUT
Apple
AAPL
$4.95T
$672K 0.94%
+12,000
New +$627K
ABBV icon
29
CALL
AbbVie
ABBV
$454B
$568K 0.79%
+7,500
New +$514K
MLNX
30
DELISTED
Mellanox Technologies, Ltd.
MLNX
$548K 0.76%
5,000
– –
ONCE
31
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$485K 0.68%
+5,000
New +$501K
ZTS icon
32
Zoetis
ZTS
$32.2B
$473K 0.66%
3,800
– –
AXTA icon
33
Axalta
AXTA
$7.22B
$452K 0.63%
15,000
+5,000
+50% +$148K
PM icon
34
Philip Morris
PM
$305B
$380K 0.53%
+5,000
New +$396K
MXIM
35
DELISTED
Maxim Integrated Products
MXIM
$343K 0.48%
5,924
– –
S
36
CALL
DELISTED
Sprint Corporation
S
$309K 0.43%
+50,000
New +$344K
AXTA icon
37
PUT
Axalta
AXTA
$7.22B
$302K 0.42%
10,000
– –
CIR
38
DELISTED
CIRCOR International, Inc
CIR
$300K 0.42%
8,000
-29,000
-78% -$1.1M
PKG icon
39
Packaging Corp of America
PKG
$22.5B
$297K 0.41%
2,800
-2,000
-42% -$203K
BHVN
40
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$250K 0.35%
6,000
-3,900
-39% -$165K
BHVN
41
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$250K 0.35%
6,000
+1,000
+20% +$42.2K
IBB icon
42
PUT
iShares Biotechnology ETF
IBB
$9.44B
$249K 0.35%
+2,500
New +$262K
GOOG icon
43
Alphabet (Google) Class C
GOOG
$3.99T
$244K 0.34%
4,000
-2,000
-33% -$118K
RRGB icon
44
Red Robin
RRGB
$136M
$233K 0.32%
+7,000
New +$230K
ROX
45
DELISTED
Castle Brands, Inc.
ROX
$189K 0.26%
+150,000
New +$121K
LUMN icon
46
Lumen
LUMN
$6.45B
$157K 0.22%
12,540
– –
CPE
47
DELISTED
Callon Petroleum Company
CPE
$113K 0.16%
+2,615
New +$128K
CRNT icon
48
Ceragon Networks
CRNT
$197M
$94K 0.13%
35,000
-15,300
-30% -$40.2K
BMY icon
49
PUT
Bristol-Myers Squibb
BMY
$128B
– –
-5,000
Closed -$227K
CNC icon
50
PUT
Centene
CNC
$31.6B
– –
-5,000
Closed -$262K
1
2
3 4

Similar funds

PSF
Pacific Sun Financial Los Angeles, California $206M AUM 17.72% 1-Year Est. Return
T
Tableaux Stockbridge, Massachusetts $206M AUM 21.58% 1-Year Est. Return
BOJHT
Bank of Jackson Hole Trust Jackson, Wyoming $207M AUM 22.49% 1-Year Est. Return
ACM
Accent Capital Management Centerville, Ohio $206M AUM 29.56% 1-Year Est. Return
MW
Melia Wealth Tulsa, Oklahoma $207M AUM 13.85% 1-Year Est. Return
IAM
Infusive Asset Management New York $207M AUM 8.24% 1-Year Est. Return
TS
Twin Securities New York $206M AUM 77.79% 1-Year Est. Return
ASI
All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return

Harvest Management's Q3 2019 Portfolio in Review

As of Q3 2019, Harvest Management held 77 positions worth $71.8M, down 1.4% from $72.8M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Harvest Management withdrew a net $4.16M in Q3 2019, closing 29 positions and reducing 7 holdings. Its most notable exit was Red Hat Inc, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 20% a quarter earlier, followed by Technology and Materials.

Against the trend, Harvest Management opened a new position in Alder Biopharmaceuticals worth $3.02M.

  • Harvest Management's largest Q3 2019 buy was Alder Biopharmaceuticals: 160,283 shares worth $3.02M.
  • Harvest Management added most to Allergan plc in Q3 2019, an estimated $6.32M increase.
  • Harvest Management's biggest Q3 2019 reduction was CIRCOR International, Inc, cutting an estimated $1.1M.
  • Harvest Management fully exited Red Hat Inc in Q3 2019, selling an estimated $13M.
  • Harvest Management's ten largest holdings make up 66% of its $71.8M portfolio in Q3 2019.
  • Harvest Management opened 23 new positions and closed 29 in Q3 2019.
  • Harvest Management's portfolio value fell 1.4% quarter-over-quarter to $71.8M.

Based on Harvest Management's 13F filing for Q3 2019, filed 30 Oct 2019.